Victor Velculescu, the co-leader of the Stand Up To Cancer-KWFKankerbestrijding Colorectal Cancer Early Detection Dream Team published a paper in Science Translational Medicine detailing the development of ARTEMIS, a promising new technique offers a new avenue for both cancer detection and monitoring science.org/doi/10.1126/sc…

Pediatric Stand Up To Cancer Catalyst®-Bristol Myers Squibb Team Leader Uri Tabori has published a paper highlighting the potential of cutting-edge cellular and molecular analysis techniques to define processes controlling tumorigenesis in npj Journals nature.com/articles/s4169…

Out now in Gastroenterology! Anirban Maitra at MD Anderson Cancer Center and Michael Goggins at Johns Hopkins Medicine present the results of the GENERATE study in #pancreaticcancer and its impact on patient-reported psychological outcomes. Lustgarten Foundation gastrojournal.org/article/S0016-…

Charles Swanton of the Stand Up To Cancer-LUNGevity Foundation-American Lung Association Lung Cancer Interception Dream Team published in Nature Communications about TRACERx-PHLEX for deep cell phenotyping and spatial analysis of multiplexed imaging nature.com/articles/s4146…

Josh Jang of the Van Andel Institute (VAI) - Stand Up To Cancer Epigenetics Dream Team led by Steve Baylin and Peter Jones has uncovered a link between a gene in the AHR pathway and our body’s ability to react to certain cancer immunotherapies. #immunotherapy vai.org/article/new-re…

Uri Tabori of the Pediatric Stand Up To Cancer Catalyst®-Bristol Myers Squibb published a case report in npj Journals Precision Oncology about precision immune-oncology in four malignant tumors in siblings with CMMRD nature.com/articles/s4169…

Donation dollars in action! A new #StandUpToCancer-funded trial eliminated or shrunk #melanoma tumors in 70% of patients. The study, published in Nature Communications, tested a new drug combination – targeted therapy and #immunotherapy – before surgery. Read more:

Nature Communications Thanks to Drs. Block and Hieken with the SU2C Catalyst Research Team at Mayo Clinic Comprehensive Cancer Center; and to our donor @Genentech!

Victor Velculescu, from the Stand Up To Cancer-KWFKankerbestrijding MEDOCC team and the Stand Up To Cancer-American Lung Association-LUNGevity Foundation Dream Team. published in Cancer Discovery about the Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection aacrjournals.org/cancerdiscover…

Soft-tissue sarcomas are very aggressive cancers of the muscles, fat, and connective tissues. With little progress for decades, a breakthrough is game-changing. This #SarcomaAwarenessMonth, we are highlighting a clinical trial funded by #StandUpToCancer, which showed very

A review in Nature Reviews Cancer by Stand Up To Cancer Convergence™ Member Calvin Kuo discusses the evolving field of tumor organoids to recapitulate the tumor microenvironment and using them to study tumor immunity, drug development and precision medicine nature.com/articles/s4156…

Biosocial determinants at the intersection of biology and experiences inform about the complexity of cancer disparities according to Robert Winn, leader of the Stand Up To Cancer Lung Cancer Health Equity Research Team in Trends in Cancer sciencedirect.com/science/articl…

A paper in Nature Communications by Uri Tabori & Anirban Das of the Pediatric Stand Up To Cancer-Bristol Myers Squibb Catalyst® team describes that while there are patterns of immune activation in pediatric brain tumors, the TME remains an independent feature from diagnosis nature.com/articles/s4146…

Nada Jabado of the Pediatric Stand Up To Cancer-@ bmsnews Catalyst Team published in Nature Communications about how characterization of the TME of oncohistone-mutant gliomas can provide insight into modulating the myeloid infiltration to benefit patients nature.com/articles/s4146…

Fabian Robles of the UT Southwestern Medical Center Stand Up To Cancer Diversity in Early Development Clinical Trials Research Team presented and had a poster Multiple Myeloma RF Health Equity Summit about Inclusivity in Clinical Trials: Uncovering Gaps in Equitable Clinical Trials Enrollment for LatinX Populations

Wonderful talk from gg at Dana-Farber and Harvard Medical School on the therapeutic potential of peptides in #pancreas cancer. AACR Lustgarten Foundation

A treasure trove of correlate results from the PASS-01 trial in #panreaticcancer were presented today at #AACRpan24 by Grainne O'Kane from Princess Margaret Cancer Centre . Lustgarten Foundation Dr. Elizabeth Jaffee Johns Hopkins Medicine

Day 3 poster session at #AACRPan24 featured two PASS-01 posters! Dr. Amber Habowski described preliminary results from #PDO work in the Tuveson lab, and Grainne O'Kane showed #genomic and #transcriptomic results in #pancreaticcancer patients. #PDAC

Robert Winn, Andrew Chan, Folasade P. May, Chris Sander, Aki Smith, John Carpten, and Ivis Febus-Sampayo will discuss "Advances in Early Detection and Screening" in a special #AACRdisp24 session organized by Stand Up To Cancer. Stand Up To Cancer

Dr. Robert Winn discussed the impact of ZNA—zip code neighborhood of association—on cancer disparities at the Stand Up To Cancer special session on early detection and screening at #AACRdisp24. AACR is the proud Scientific Partner of Stand Up To Cancer. SU2Cscience Dr. Rob Winn @VCUmassey